Index of reports
> Cases resulting in disability (18)
| |
Retinal Detachment (3),
Paranoia (2),
Somnolence (2),
Grand MAL Convulsion (2),
Hallucination, Visual (2),
Visual Disturbance (2),
Dizziness (2),
Hallucination (2),
Drug Interaction (1),
Pharmaceutical Product Complaint (1) |
Below is the selection of adverse event reports related to Keppra (Levetiracetam) that includes cases resulting in disability.
Adverse event in 7 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United Kingdom on 2007-10-25
Patient: 7 year old female, weighing 26.9 kg (59.2 pounds)
Adverse reactions / side effects: Agitation, Muscle Twitching, Somnolence, Aggression, Anxiety, Affect Lability, TIC, Tearfulness, Eye Disorder
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 700 mg 2/d po
Administration route: Oral
Indication: Partial Seizures
Start date: 2006-12-14
End date: 2007-01-01
Keppra
Dosage: 600 mg 2/d po
Administration route: Oral
Indication: Partial Seizures
Start date: 2007-01-01
Other drugs received by patient: Valproate Sodium
Adverse event in 57 year old male receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-19
Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)
Adverse reactions / side effects: Retinal Detachment
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Dosage: dosage form: vial.
Start date: 2007-05-07
End date: 2007-08-21
Ribavirin
Dosage: 1200/1600 mg blinded therapy
Administration route: Oral
Start date: 2007-05-07
End date: 2007-09-04
Lamictal
Indication: Drug USE FOR Unknown Indication
Cymbalta
Indication: Drug USE FOR Unknown Indication
Keppra
Indication: Drug USE FOR Unknown Indication
Dyazide
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug
Adverse event in 57 year old male receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-19
Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)
Adverse reactions / side effects: Retinal Detachment
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Dosage: dosage form: vial.
Start date: 2007-05-07
End date: 2007-08-21
Ribavirin
Dosage: 1200/1600 mg blinded therapy
Administration route: Oral
Start date: 2007-05-07
End date: 2007-09-04
Lamictal
Indication: Drug USE FOR Unknown Indication
Cymbalta
Indication: Drug USE FOR Unknown Indication
Keppra
Indication: Drug USE FOR Unknown Indication
Dyazide
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug
Adverse event in 50 year old female receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-17
Patient: 50 year old female
Adverse reactions / side effects: Drug Interaction, Drug Level Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 500 mg 2/d po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-06-01
Tegretol
Dosage: 400 mg 2/d po
Administration route: Oral
Indication: Epilepsy
Start date: 2005-09-01
Adverse event in 11 year old female receiving Keppra (Levetiracetam)
Reported by a physician from Finland on 2007-10-15
Patient: 11 year old female, weighing 45.5 kg (100.1 pounds)
Adverse reactions / side effects: Dysstasia, Deafness Unilateral, Dizziness
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 250 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-05-14
End date: 2007-05-27
Keppra
Dosage: 750 mg /d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-05-28
End date: 2007-06-10
Keppra
Dosage: 500 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-06-10
End date: 2007-06-01
Keppra
Dosage: 750 mg /d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-06-01
Keppra
Dosage: 625 mg /d po
Administration route: Oral
Indication: Convulsion
Other drugs received by patient: Renitec; Cozaar; Sandimmune; Kalcipos; Prednisolone; Omeprazole
Adverse event in 70 year old male receiving Keppra (Levetiracetam)
Reported by a consumer/non-health professional from Germany on 2007-10-04
Patient: 70 year old male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Myoclonus, Sleep Disorder, Cerebellar Syndrome
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 1000 mg 3/d po
Administration route: Oral
Indication: Myoclonus
Start date: 2007-04-01
End date: 2007-09-01
Aspirin
Dosage: 100 mg 1/d po
Administration route: Oral
Indication: Status Epilepticus
Metoprolol Succinate
Dosage: 1.5 df /d po
Administration route: Oral
Ramipril
Dosage: 2.5 df 1/d po
Administration route: Oral
Inegy. Mfr: NOT Specified
Adverse event in 57 year old male receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-10-01
Patient: 57 year old male, weighing 94.5 kg (207.9 pounds)
Adverse reactions / side effects: Retinal Detachment
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Start date: 2007-05-07
End date: 2007-08-21
Ribavirin
Dosage: 1200/1600 mg blinded therapy
Administration route: Oral
Start date: 2007-05-07
End date: 2007-09-04
Lamictal
Indication: Drug USE FOR Unknown Indication
Cymbalta
Indication: Drug USE FOR Unknown Indication
Keppra
Indication: Drug USE FOR Unknown Indication
Dyazide
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Unspecified Drug; Singulair; Aciphex; Albuterol; Multivitamin NOS; Unspecified Drug
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a physician from Germany on 2007-06-18
Patient: female, weighing 58.6 kg (128.9 pounds)
Adverse reactions / side effects: Grand MAL Convulsion, Viral Infection, Visual Disturbance, Hallucination, Visual, Blood Glucose Fluctuation, Abdominal Pain Upper
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Keppra
Dosage: 2500 mg /d po
Administration route: Oral
Indication: Epilepsy
End date: 2006-06-11
Keppra
Dosage: 1500 mg 2/d po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-06-12
End date: 2006-06-19
Keppra
Dosage: 2750 mg /d po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-06-20
Keppra
Dosage: 1000 mg 2/d po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-01-01
Codicaps
Dosage: 1 df 2/d po
Administration route: Oral
Indication: Viral Infection
Start date: 2007-02-27
End date: 2007-03-01
Other drugs received by patient: Ergenyl Chrono; Valproate Chrono; Topiramate; Dociton; Enalapril; Humininsulin Normal
Adverse event in 77 year old female receiving Keppra (Levetiracetam)
Reported by a physician from France on 2007-05-31
Patient: 77 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Liver Injury, Contusion, Haemothorax, Multiple Injuries, Pulmonary Oedema, Depression, Lung Injury, Cervical Vertebral Fracture, Catatonia, Lumbar Vertebral Fracture, Lung Disorder, Staphylococcal Infection, Respiratory Failure, Suicide Attempt, Mental Disorder, Facial Bones Fracture, Heart Injury, Herpes Virus Infection
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Keppra
Dosage: 750 mg/d; po
Administration route: Oral
Indication: Epilepsy
Start date: 2007-02-01
End date: 2007-04-01
Keppra
Dosage: nas
Indication: Epilepsy
Start date: 2007-04-01
End date: 2007-04-01
Other drugs received by patient: Mysoline, 0.5 DF 1 / D; Mopral / 00661201 / , 10mg 1 / D
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a physician from Germany on 2007-03-27
Patient: female
Adverse reactions / side effects: Grand MAL Convulsion, Visual Disturbance, Hallucination, Visual, Blood Glucose Increased
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 2500 mg /d po
Administration route: Oral
Indication: Epilepsy
End date: 2006-06-11
Keppra
Dosage: 1500 mg 2/d po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-06-12
End date: 2006-06-19
Keppra
Dosage: 2750 mg /d po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-06-20
Other drugs received by patient: Ergenyl Chrono; Valproate Chrono; Topiramate; Dociton; Enalapril Maleate; Huminsulin Normal
Adverse event in female receiving Keppra (Levetiracetam)
Reported by a physician from Germany on 2007-03-16
Patient: female, weighing 51.0 kg (112.2 pounds)
Adverse reactions / side effects: Anticonvulsant Drug Level Above Therapeutic, Anticonvulsant Drug Level Below Therapeutic
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Keppra
Dosage: 1 g 3/d;po
Administration route: Oral
Start date: 2006-10-01
Valproic Acid
Dosage: 500 mg 6/d;po
Administration route: Oral
Carbamazepine
Dosage: 400 mg;po
Administration route: Oral
Start date: 2007-02-07
End date: 2007-02-27
Adverse event in 42 year old male receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from Switzerland on 2007-03-16
Patient: 42 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Paranoia, Drug Intolerance, Hallucination, Treatment Noncompliance
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 500 mg 2/d; po
Administration route: Oral
Start date: 2006-11-23
End date: 2006-12-07
Keppra
Dosage: 750 mg 2/d;po
Administration route: Oral
Start date: 2006-12-08
End date: 2006-12-29
Temesta / 00273201 /
Dosage: 5 mg 1/d;po (few months)
Administration route: Oral
Prazine / 00049902 /
Dosage: 100 mg 1/d;po (few months)
Administration route: Oral
Subutex
Dosage: 1 mg 1/d;po (few months)
Administration route: Oral
Dormicum / 00036201 /
Dosage: 30 mg 1/d;po (few months)
Administration route: Oral
Rohypnol
Dosage: 1 mg 1/d;po (few months)
Administration route: Oral
Lisitril
Dosage: 5 mg 1/d;po
Administration route: Oral
Start date: 2006-03-01
End date: 2006-12-13
Metoprolol Succinate
Dosage: 50 mg 1/d; po (few months)
Administration route: Oral
Plavix
Dosage: 75 mg 1/d;po (few months)
Administration route: Oral
Other drugs received by patient: Selipran
Adverse event in 42 year old male receiving Keppra (Levetiracetam)
Reported by a physician from Switzerland on 2007-03-13
Patient: 42 year old male, weighing 66.0 kg (145.2 pounds)
Adverse reactions / side effects: Paranoia, Pharmaceutical Product Complaint, Hallucination
Adverse event resulted in: disablity
Suspect drug(s):
Listril (Ngx) (Lisinopril) Tablets, 5MG
Dosage: 5 mg, qd, oral
Administration route: Oral
Start date: 2006-03-01
End date: 2006-12-13
Keppra
Dosage: 750 mg, bid, oral
Administration route: Oral
Start date: 2006-11-23
End date: 2006-12-29
Lorazepam
Dosage: 5 mg, qd, oral
Administration route: Oral
Prazine / NET / (Promazine Hydrochloride)
Dosage: 100 mg, qd, oral
Administration route: Oral
Subutex
Dosage: 1 mg, qd, oral
Administration route: Oral
Dormicum Roche (Midazolam Maleate)
Dosage: 30 mg, qd, oral
Administration route: Oral
Rohypnol (Flunitrazepam) Film-Coated Tablet, 1MG
Dosage: 1 mg, qd, oral
Administration route: Oral
Beloc ZOK (Metoprolol Succinate) Tablet
Dosage: 50 mg, qd, oral
Administration route: Oral
Plavix
Other drugs received by patient: Selipran (Pravastatin Sodium) Tablet, 40 MG
Adverse event in 36 year old male receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United States on 2007-02-27
Patient: 36 year old male, weighing 79.5 kg (175.0 pounds)
Adverse reactions / side effects: Speech Disorder, Aphasia, Dizziness, Gait Disturbance, Feeling Drunk
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 500 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-01-08
End date: 2007-02-08
Keppra
Dosage: 750 mg 2/d po
Administration route: Oral
Indication: Convulsion
Start date: 2007-02-08
Other drugs received by patient: Tylenol; Advil; Darvocet
Adverse event in 6 year old male receiving Keppra (Levetiracetam)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-02-05
Patient: 6 year old male, weighing 28.0 kg (61.6 pounds)
Adverse reactions / side effects: Unresponsive TO Stimuli, Disturbance in Attention, Ill-Defined Disorder, Somnolence
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 600 mg 2/d
Indication: Convulsion
Start date: 2006-04-01
Keppra
Indication: Convulsion
Start date: 2006-11-01
Other drugs received by patient: Epilin; Ethosuxemide
Adverse event in 17 year old female receiving Keppra (Levetiracetam)
Reported by a physician from United States on 2007-01-31
Patient: 17 year old female
Adverse reactions / side effects: Cognitive Disorder, Coordination Abnormal
Adverse event resulted in: disablity
Suspect drug(s):
Keppra
Dosage: 500 mg 2/d po
Administration route: Oral
Indication: Myoclonic Epilepsy
Start date: 2006-12-01
End date: 2006-12-01
Keppra
Dosage: 500 mg /d po
Administration route: Oral
Indication: Myoclonic Epilepsy
Start date: 2006-12-01
End date: 2006-01-01
Other drugs received by patient: Wellbutrin; Synthroid; Effexor
Adverse event in 35 year old male receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from Italy on 2007-01-22
Patient: 35 year old male
Adverse reactions / side effects: Abasia, Neoplasm Progression, Meningioma
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Keppra
Dosage: 750 mg
Indication: Epilepsy
Start date: 2006-03-14
Depakote
Dosage: 1500 mg
Indication: Epilepsy
Start date: 2006-03-14
Adverse event in 17 year old male receiving Keppra (Levetiracetam)
Reported by a individual with unspecified qualification from United Kingdom on 2007-01-18
Patient: 17 year old male, weighing 40.6 kg (89.3 pounds)
Adverse reactions / side effects: Pruritus, Abnormal Behaviour, Intentional Self-Injury
Adverse event resulted in: disablity
Suspect drug(s):
Keppra (Levetiracetam)
Other drugs received by patient: Lactulose Solution; Movicol / 01053601 /
|
